Brevan Howard Capital Management LPBrevan Howard Capital Management LP

Institutional investor · Portfolio as of Q2 2017

Top Holdings3 positions

Checking export access…
Activity:

CME Group Inc.

102,553$12.8M65.1%$64.90+37.79%
6 qtrssince 2016-Q1
Unchanged
0
LQDLQD
ETF

ISHARES TR

39,599$4.8M24.2%$86.540.00%
1 qtr
New
86
CBLAQCBLAQDelisted
REIT

CBL & ASSOC PPTYS INC

250,000$2.1M10.7%——
1 qtr
New
83
$19.7M
AUM
3
Positions
Q2 2017
Filing
HI score · 1.5/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
$ moved · Q2'17
New45%Increased0%Decreased0%Exited55%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.7 quarters
<1Q67%1-4Q0%1-2Y33%2Y+0%

Brevan Howard Capital Management LP manages $19.7M across 3 positions as of Q2 2017. Top holdings: CME (65.1%), LQD (24.2%), CBLAQ (10.7%). Fund DNA: Diversified Scout. HoldingsIntel Score: 1.5/5.0.

Q2 2017 Summary

Added 2 new positions. Top move: LQD (NEW, conviction 86). Portfolio: $20M across 3 positions.

Top holdings by portfolio weight

Total AUM$20M
CME65.12%
LQD24.19%
CBLAQ10.69%

Portfolio allocation by GICS sector

Sectors2
Financial Services65.12%
Unknown34.88%

Behavioral investing profile

Checking access…
Diversified Scout- primarily Financial Services, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L40
Conviction44
Concentration23
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
BOXBOXBOX INC
Q3 2025 → Q2 2026+136,113 shares+$3.3M
4Q
PRCTPRCTPROCEPT BIOROBOTICS CORP
Q3 2025 → Q2 2026+61,661 shares+$1.1M
4Q
RKTRKTROCKET COS INC
Q3 2025 → Q2 2026+1.1M shares+$17.7M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used